Caren Brumpt

Caren Brumpt

Auto-generated profile, based on publicly available information

Caren Brumpt

Department of Biological Haematology, Lariboisière Hospital, AP-HP, INSERM UMR-S-1140, Université de Paris, 75010 Paris, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
MKMohamad Kurdi
Mohamad Kurdi
CFCorinne Frère
Corinne Frère
JAJulien Amour
Julien Amour
CBCaren Brumpt
Caren Brumpt
JDJosée Delort
Josée Delort
IMIsabelle Martin-Toutain
Isabelle Martin-Toutain
: We report herein the successful perioperative management of a 57-year-old man with a type I Glanzmann thrombasthenia undergoing coronary artery bypass graft surgery and right carotid endarterectomy. The patient suffered from several lesions in the three major coronary arteries and in the right carotid necessitating surgery. Prophylactic human leukocyte antigen (HLA)-matched platelets transfusions were continuous administrated before, and through the immediate perioperative period. Posttransfusion platelet recovery was monitored using flow cytometry to determine the percentage of circulating platelet expressing CD61 (β3). No bleeding complications occurred during and following the procedure. The patient did not develop HLA antibodies or αIIbβ3 antibodies. Thrombophilia screening revealed a heterozygous G20210A prothrombin gene mutation. The patient also suffered from an atrial fibrillation, necessitating anticoagulation therapy. During the hospital stay, a treatment with vitamin K antagonists for stroke prevention was initiated. The patient was discharged 8 days following surgery, and no further complications occurred during the 6 months follow-up.

6 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
CRCharles de Roquetaillade
Charles de Roquetaillade
CDClaire Dupuis
Claire Dupuis
VFValérie Faivre
Valérie Faivre
ALAnne Claire Lukaszewicz
Anne Claire Lukaszewicz
CBCaren Brumpt
Caren Brumpt
Didier PayenDidier Payen
Didier Payen
Background: post-injury acquired immunodepression (AID) is frequently assessed by the diminished expression of Human Leukocyte Antigen-D Related on circulating monocytes (mHLA-DR). The relation with mortality and the occurrence of ICU-acquired infections (IAI) requires confirmation in large cohorts of patients. This study tested in a large number of ICU patients from a single center the association of mHLA-DR with mortality and secondary infections. Methods: This prospective, observational study in a surgical ICU of a French tertiary hospital reports mHLA-DR measurements (fixed flow cytometry protocol) done 1st within the 3 days post-admission and 2nd after the 7th day. The other collected parameters were: the SAPS II and SOFA scores, sex, age, comorbidity, mortality and ICU-acquired infections. The associations between mHLA-DR and outcomes were tested by adjusted Fine and Gray sub-distribution competing risk models. Findings: 1053 patients were subdivided into 4 subgroups depending on the main motif for admission. Overall, 151 patients (14.3%) died in the ICU with an independent association with the amplitude of the first mHLA-DR decrease (HR = 0.71 [0.57; 0.95], p < 0.01); 592 patients had a 2nd mHLA-DR measurement of whom 223 patients (37.7%) complicated by IAI. These patients had a lower mHLA-DR than other patients (mHLA-DR = 9.0 log vs. 9.3 log, p < 0.01). IAI occurrence was independently associated with first, the 2nd mHLA-DR level regardless the initial severity (HR = 0.66 [0.51; 0.84], p = 0.001) and second, with the slope between the 1st and 2nd values (HR = 0.62 [0.43; 0.89], p = 0.009). Interpretation: the association between the early mHLA-DR expression and ICU mortality does not improve the prediction given by the severity scores. The persistence or a decrease of low mHLA-DR expression are independent and reliable predictors of ICU-acquired infection. Funding: no financial interest

1 October 2021 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
CSClaire Bal Dit Sollier
Claire Bal Dit Sollier
NBNatacha Berge
Natacha Berge
SHSara Hamadouche
Sara Hamadouche
CBCaren Brumpt
Caren Brumpt
ASAlain Stépanian
Alain Stépanian
JDJean-Guillaume Dillinger
Jean-Guillaume Dillinger